Role of Ultrasound for Chronic Liver Disease and Hepatocellular Carcinoma Surveillance

Hailey H Choi; Shuchi K Rodgers; Aman Khurana; Leslie W Nelson; Aya Kamaya

doi:10.1016/j.mric.2021.05.005

Role of Ultrasound for Chronic Liver Disease and Hepatocellular Carcinoma Surveillance

Magn Reson Imaging Clin N Am. 2021 Aug;29(3):279-290. doi: 10.1016/j.mric.2021.05.005.

Authors

Hailey H Choi¹, Shuchi K Rodgers², Aman Khurana³, Leslie W Nelson³, Aya Kamaya⁴

Affiliations

¹ Department of Radiology and Biomedical Imaging, University of California San Francisco, 1001 Potrero Avenue Building 5 Room 1X57, San Francisco, CA 94110, USA.
² Department of Radiology, Sidney Kimmel Medical College at Thomas Jefferson University, Einstein Healthcare Network, Levy Ground, 5501 Old York Road, Philadelphia, PA 19141, USA.
³ Department of Radiology, University of Kentucky, 800 Rose Street, HX 316, Lexington, KY 40536, USA.
⁴ Department of Radiology, Stanford University, 300 Pasteur Drive H1307, Stanford, CA 94305, USA. Electronic address: [email protected].

PMID: 34243917
DOI: 10.1016/j.mric.2021.05.005

Abstract

Ultrasound plays a vital role in the evaluation of patients with chronic liver disease and in hepatocellular carcinoma (HCC) surveillance in populations at risk for developing HCC. Semiannual ultrasound for HCC surveillance is universally recommended by all liver societies around the world. Advanced ultrasound techniques, such as elastography and contrast-enhanced ultrasound, offer additional benefits in imaging evaluation of chronic liver disease. Major benefits of ultrasound include its high safety profile and relatively low cost.

Keywords: Chronic liver disease; HCC surveillance; Hepatocellular carcinoma; Ultrasound; Ultrasound elastography.

Publication types

Review

MeSH terms

Carcinoma, Hepatocellular* / diagnostic imaging
Humans
Liver Cirrhosis
Liver Neoplasms* / diagnostic imaging
Magnetic Resonance Imaging
Ultrasonography